Transforming Growth Factor-β Inhibitors Erythropoietin induction by transforming growth factor (TGF)-β inhibition is a very recent development in the possible treatment of anaemia, and in particular for myelodysplastic syndromes. Here, EPO is linked to myelodysplastic syndrome.